SWI swissinfo.ch: Alleged pharma bribery Justice ministry confirms legal aid requests in Greece-Novartis scandal

Front page - SWI swissinfo.ch

Alleged pharma bribery
Justice ministry confirms legal aid requests in Greece-Novartis scandal

    Business
    Law and order

    Reuse article

This content was published on February 10, 2018 6:16 PMFeb 10, 2018 - 18:16
A woman enters Novartis Greek offices in Athens, on Tuesday, Feb. 6, 2018.

Greece's government says it has evidence that senior politicians from the previous administration were involved in a bribery case in which Swiss drugmaker Novartis is accused of making illegal payments to fix prices and increase market access
(Keystone)

Switzerland’s Federal Office of Justice has confirmed it has received two requests for legal assistance from Greece and the United States linked to probes into Novartis and alleged bribes involving the Swiss drugmaker and Greek doctors and public officials.

The two requests for legal assistance linked to the Novartis-Greek scandal were received at the end of last year and in January 2018 and are being studied, a justice ministry official confirmed to Swiss public television, RTS, and the Swiss News Agency on Saturday.

+ Greek politicians named in Novartis scandal

The Greek parliament announced on Tuesday the results of a judicial investigation into alleged bribes paid to public officials by Basel-based Novartisexternal link over nearly a decade to boost subscriptions of their products at public hospitals. The ten prominent politicians linked to the bribery scandal include two former Greek prime ministers and eight former ministers. They are alleged to have been involved in approving Novartis contracts and overcharging in return for kickbacks. All deny the allegations.

Greece's Justice Minister Stavros Kontonis last year said Novartis had likely bribed "thousands" of doctors and civil servants to promote its products. He also accused Novartis of continuing to sell "overpriced" drugs even after the country was plunged into economic crisis in 2010 and huge cuts were imposed on state budgets, leaving many Greeks without access to affordable medicine.

Novartis overcharges alone are estimated to have cost the Greek state some €3 billion euros ($3.7 billion). Overall, similar practises across the health sector cost Greece some €23 billion between 2000 and 2015, investigators have said.

The Greek branch of Novartis has issued a statement saying it was "aware of the media reports about our business practices" in Greece and that it was cooperating with the authorities, the Swiss News Agency said.
Novartis, one of Switzerland’s largest pharmaceutical companies, was also the target of corruption investigations last year in Korea and Turkey.
Swiss pharma
Greece investigates Novartis for alleged bribery

Investigations into allegations of corruption against the pharma giant were announced following the attempted suicide of a Greek Novartis official.

    Business
    Law and order

SDA-ATS/RTS/sb
Neuer Inhalt

Horizontal Line
subscription form

Form for signing up for free newsletter.

Sign up for our free newsletters and get the top stories delivered to your inbox.
Email address
Top stories (weekly)
Latest news (daily)
Business (weekly)
Politics (weekly)
Society (weekly)
Fintech (monthly)

Click here to see more newsletters
swissinfo EN

The following content is sourced from external partners. We cannot guarantee that it is suitable for the visually or hearing impaired.

Join us on Facebook!
Comment on this article:
|
Log In

During a test phase, unregistered users can also comment.

Write a comment...
Related Stories
building
Pharma
Greek politicians named in Novartis scandal

Greece's parliament has linked ten prominent politicians to a bribery scandal involving Swiss drug-maker Novartis.

    Business

See in another language: 1
Novartis, one of Switzerland’s largest pharmaceutical companies, was also the target of corruption investigations last year in Korea and Turkey.
Swiss pharma
Greece investigates Novartis for alleged bribery

Investigations into allegations of corruption against the pharma giant were announced following the attempted suicide of a Greek Novartis official.

    Business
    Law and order

Novartis chief Vasant Narasimhan speaks at a podium.
Digital technology
New Novartis chief eyes productivity revolution
By Sarah Neville and Ralph Atkins

Vas Narasimhan estimates that using digital technology more efficiently could save up to 25% on the cost of clinical trials.
1 There is one comment on this article.

    Business
    Sci & Tech

Novartis has stated that while it acknowledges this misconduct, it does not believe that Novartis Korea senior management were aware of it at the time.
Kickbacks
Novartis Korea staff indicted for corruption

Basel-based pharmaceutical company Novartis has confirmed news reports that six senior employees of their subsidiary in South Korea have been ...

    Business
    Law and order

Human T cells belonging to cancer patients arrive at Novartis's Morris Plains, N.J., facility
Novartis cancer therapy
Will exclusive collaborations yield more drug breakthroughs? 
By Celia Luterbacher

Recently FDA-approved, Novartis's pioneering immunotherapy was developed through an agreement with University of Pennsylvania researchers.

    in depth: Switzerland discovers

    Business
    Sci & Tech
    Education
    Health

See in other languages: 3
Novartis has rejected the unwelcome allegations as baseless
Whistleblower allegation
Novartis hits back at Turkey bribe claims

Swiss pharmaceutical giant Novartis has dismissed claims from an internal whistleblower that it bribed Turkish officials.

    Business
    Law and order

syringe
Drugs and Tech
Pharma turns to big data to gauge care and pricing
By Sarah Neville, Financial Times

Struggling to keep pace with digitisation, big pharma companies are turning to big data to drive future growth. Swiss-based Novartis is no different.

    Business

Hindu gods "keep watch" over the drugs at a clinic in Pune near Mumbai, India
A healthy balance?
Doing business in the developing world’s pharmacy
By Susan Misicka, Mumbai

Traffic noise floods the busy waiting room at a public hospital in southern Mumbai, where it’s first-come, first-served.
2 There are 2 comments on this article.

    Sci & Tech
    Business
    Health

Footer

    The company | Partnerships | Imprint | Jobs | Play SWI | Newsletter subscription | Contact

Back to top
World partners:

    Radio Netherlands Worldwide | Radio Canada International | Radio Praha | Polskie Radio

    RTS | SRF | RSI | RTR | SWI

Front page - SWI swissinfo.ch
swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR